| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.26 | 8e-06 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0002 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.24 | 0.0003 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0007 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0008 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |